🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

15 results for “Esperion” Clear

  1. Bempedoic Acid + Ezetimibe Fixed-Dose Combination

    Esperion Therapeutics

    Hyperlipidemias

    phase 3 other completed

    1 trial

  2. Bempedoic acid 180 mg tablet

    Esperion Therapeutics

    Cardiovascular Diseases

    phase 3 small molecule completed

    1 trial

  3. ETC-1002

    Esperion Therapeutics

    Hypercholesterolemia

    phase 3 small molecule completed

    6 trials

  4. bempedoic acid

    Esperion Therapeutics

    Hypercholesterolemia

    phase 3 small molecule completed

    5 trials

  5. Bempedoic acid + Ezetimibe FDC Oral Tablet

    Esperion Therapeutics

    Diabetes

    phase 2 small molecule completed

    1 trial

  6. Bempedoic acid 180mg

    Esperion Therapeutics

    Hypercholesterolemia

    phase 2 small molecule completed

    2 trials

  7. Bempedoic acid, bempedoic acid

    Esperion Therapeutics

    Heterozygous familial hypercholesterolemia, Heterozygous Familial Hypercholesterolemia

    phase 2 small molecule active

    1 trial

  8. ETC-1002

    Esperion Therapeutics

    Hyperlipidemia

    phase 2 small molecule completed

    2 trials

  9. ETC-1002

    Esperion Therapeutics

    Dyslipidemia

    phase 2 small molecule completed

    1 trial

  10. ETC-1002

    Esperion Therapeutics

    Safety Evaluation of Escalating Doses

    phase 1 small molecule completed

    1 trial

  11. ETC-1002 or placebo

    Esperion Therapeutics

    Mild Dyslipidemia

    phase 1 small molecule completed

    1 trial

  12. [14C-ETC-1002]

    Esperion Therapeutics

    Hyperlipidemia

    phase 1 small molecule completed

    1 trial

  13. Bempedoic Acid / Ezetimibe Oral Tablet

    Esperion Therapeutics

    Cardiovascular Diseases

    approved small molecule active

    1 trial

  14. Bempedoic Acid 180 MG Oral Tablet

    Esperion Therapeutics

    Healthy Lactating Women

    approved small molecule completed

    1 trial

  15. Cardiopulmonary Exercise Testing

    Esperion Therapeutics

    Intrauterine Growth Restriction

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources